SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 40.30
+0.09 (0.22%)
Oct 9, 2026, 4:00 PM EDT
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 3.18 billion as of October 9, 2026. It is the 15,227th most valuable company in the world and the 4,167th biggest in China. Its market cap has decreased by 15.94% in one year.
Market Cap
3.18B
Enterprise Value
2.61B
Revenue
824.77M
Global Rank
Country Rank
#4,167 China
PE Ratio
57.88
ChartMarket Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has decreased from 4.48B to 3.18B, a decrease of -28.91%. That is a compound annual growth rate of -7.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 3.18B | -22.56% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
| May 17, 2022 | 4.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Strong Biotechnologies,Inc. | 7.10B |
| Shanghai Runda Medical Technology | 6.03B |
| Maccura Biotechnology Co.Ltd | 5.79B |
| Cowealth Medical China | 5.48B |
| Shanghai Labway Clinical Laboratory | 4.69B |
| Berry Genomics Co.,Ltd | 3.99B |
| Medicalsystem Biotechnology | 3.96B |
| Guangdong Hybribio Biotech | 3.94B |